Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H (DE:JIL)

FRANKFURT:JIL

JIL

Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H

RESEARCH TOOLSreports

Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H (JIL) Price & Analysis

1 Followers

JIL Stock Chart & Stats

€0.23

Market closed

€0.23

Day’s Range― - ―

52-Week Range€0.03 - €0.27

Previous CloseN/A

VolumeN/A

Average Volume (3M)166.00

Market Cap

€144.48M

Enterprise Value€732.85M

Total Cash (Recent Filing)€748.30M

Total Debt (Recent Filing)€72.40M

Price to Earnings (P/E)5.2

Beta>-0.01

Next Earnings

Aug 13, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.02

Shares Outstanding172,500,000

10 Day Avg. Volume0

30 Day Avg. Volume166

Financial Highlights & Ratios

PEG Ratio0.15

Price to Book (P/B)0.45

Price to Sales (P/S)0.82

P/FCF Ratio3.48

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue GrowthConsistent revenue growth indicates a strong market presence and demand for the company's products, supporting long-term financial stability.

Margin SustainabilityHigh and stable margins reflect efficient cost management and pricing power, which are crucial for sustaining profitability over time.

Balance Sheet HealthA low debt-to-equity ratio indicates minimal leverage, reducing financial risk and enhancing the company's ability to invest in growth opportunities.

Bears Say

Free Cash Flow DeclineA decline in free cash flow can limit the company's ability to fund new projects or return capital to shareholders, potentially impacting growth and investor returns.

Operating Cash Flow ReductionReduced operating cash flow may indicate challenges in converting revenue into cash, which could affect liquidity and operational flexibility.

Decreased Cash Flow GrowthDecreased cash flow growth can signal potential issues in sustaining financial performance, affecting future investment capabilities and stability.

JIL FAQ

What was Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s price range in the past 12 months?

Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H lowest stock price was €0.03 and its highest was €0.27 in the past 12 months.

What is Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s market cap?

Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s market cap is €144.48M.

When is Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s upcoming earnings report date?

Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s upcoming earnings report date is Aug 13, 2026 which is in 128 days.

How were Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s earnings last quarter?

Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H released its earnings results on Mar 31, 2026. The company reported €0.021 earnings per share for the quarter, beating the consensus estimate of N/A by €0.021.

Is Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H overvalued?

According to Wall Street analysts Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H pay dividends?

Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H does not currently pay dividends.

What is Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s EPS estimate?

Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H have?

Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H has 172,500,000 shares outstanding.

What happened to Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H’s price movement after its last earnings report?

Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H reported an EPS of €0.021 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.439%.

Which hedge fund is a major shareholder of Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H?

Currently, no hedge funds are holding shares in DE:JIL

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H

Jilin Province Huinan Changlong Bio-pharmacy Company Limited engages in the manufacture and distribution of Chinese medicines and pharmaceutical products in the People's Republic of China. It offers tablets, capsules, pills, Chinese medicine pretreatment and extraction products, powders for injections, lyophilized powder for injections, small volume injection solutions, APIs, and granules. The company markets its products under the Changlong and Qing Tong brands. The company was formerly known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited. Jilin Province Huinan Changlong Bio-pharmacy Company Limited was founded in 1989 and is based in Kowloon, Hong Kong.